KRT18 and neoplasm: In this study, we investigated the transcriptomic and spatial characteristics of hybrid circulating tumor cell (CTC)-like cells co-expressing epithelial (KRT18) and immune (CD45/PTPRC) markers, termed KP_Pos, to elucidate their origin and clinical significance.